/sc-assets/prd/practices/e1272c1d-8bc3-4637-8a83-840ee1c01843/XxpeVG53rNf2pVS_-arjnicqmgWT1hXGk6WlREoSpAieaIVpKMFMtHQXMvafoPJyGIuDq3iEGGAC3__Bf1NPPE44D8cbu7Ww.jpeg)
STI Pathogen Detection
FOR MORE INFORMATION PLEASE CONTACT THE OFFICE
The CDC reports that 1 in 5 people in the U.S. have a sexually transmitted infection. There are approximately 26 million new sexually transmitted infections in the United States, trending upward, every year. The prevalence of asymptomatic STIs is a leading factor in the increasing incidence of STI transmission in the U.S. Screening is an important approach to identify and treat infected individuals, who would otherwise go undetected. Undetected STIs cause many harmful, often irreversible, and costly clinical complications.
Our Molecular Testing Services
PathMD provides a variety of comprehensive molecular PCR based solutions that provide rapid and precise pathogen identification. Antibiotic stewardship is enhanced by testing the most common antimicrobial resistance markers. Results are posted within 24 hours and provide clients with pertinent and clear information to develop treatment regimens.
PathMD is continually expanding our portfolio by offering clinical testing focused on specific specialties. Whether it be Gastroenterology, Urology, or Women’s Health, we strive to make it easier for physicians to trust our lab with most of their testing needs.
PathMD is continually expanding our portfolio by offering clinical testing focused on specific specialties. Whether it be Gastroenterology, Urology, or Women’s Health, we strive to make it easier for physicians to trust our lab with most of their testing needs.